IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer.
Saved in:
| Title: | IGFBP-3 methylation-derived deficiency mediates the resistance to cisplatin through the activation of the IGFIR/Akt pathway in non-small cell lung cancer. |
|---|---|
| Authors: | Cortés-Sempere, M1, de Miguel, M P2, Pernía, O3, Rodriguez, C3, de Castro Carpeño, J4, Nistal, M5, Conde, E6, López-Ríos, F6, Belda-Iniesta, C7, Perona, R1, de Caceres, I Ibanez3 |
| Source: | Oncogene. 3/7/2013, Vol. 32 Issue 10, p1274-1283. 10p. 1 Color Photograph, 1 Black and White Photograph, 1 Diagram, 3 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
